Recursion Pharmaceuticals, Inc. SEC filings RXRX
Recursion Pharmaceuticals, Inc. has 991 filings in SEC EDGAR's recent list, going back to Apr 2, 2014. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations, officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| 4 | Insider transaction | Nov 4, 2026 | Nov 3, 2026 |
| 3 | Initial insider ownership | Nov 4, 2026 | Oct 31, 2026 |
| 144 | Notice of proposed sale | Nov 3, 2026 | — |
| 10-Q | Quarterly report | Nov 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Nov 2, 2026 | Oct 31, 2026 |
| 424B5 | Prospectus supplement | Oct 15, 2026 | — |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure, Other events
|
Oct 15, 2026 | Oct 15, 2026 |
| 424B5 | Prospectus supplement | Oct 15, 2026 | — |
| 4 | Insider transaction | Oct 7, 2026 | Oct 6, 2026 |
| 4 | Insider transaction | Oct 7, 2026 | Oct 6, 2026 |
| 144 | Notice of proposed sale | Oct 6, 2026 | — |
| 144 | Notice of proposed sale | Oct 6, 2026 | — |
| 4 | Insider transaction | Oct 2, 2026 | Oct 1, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 21, 2026 | Sep 15, 2026 |
| 4 | Insider transaction | Sep 16, 2026 | Sep 15, 2026 |
| 4 | Insider transaction | Sep 10, 2026 | Sep 8, 2026 |
| 144 | Notice of proposed sale | Sep 8, 2026 | — |
| 4 | Insider transaction | Sep 2, 2026 | Sep 1, 2026 |
| 144 | Notice of proposed sale | Sep 1, 2026 | — |
| 144 | Notice of proposed sale | Aug 21, 2026 | — |
| 144 | Notice of proposed sale | Aug 20, 2026 | — |
| 144 | Notice of proposed sale | Aug 19, 2026 | — |
| 4 | Insider transaction | Aug 18, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 17, 2026 |
| 144 | Notice of proposed sale | Aug 18, 2026 | — |
| 144 | Notice of proposed sale | Aug 13, 2026 | — |
| 144 | Notice of proposed sale | Aug 12, 2026 | — |
| 144 | Notice of proposed sale | Aug 10, 2026 | — |
| 144 | Notice of proposed sale | Aug 7, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 7, 2026 | — |
| 4 | Insider transaction | Aug 6, 2026 | Aug 4, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| 144 | Notice of proposed sale | Aug 4, 2026 | — |
| 144 | Notice of proposed sale | Aug 4, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 31, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 31, 2026 | — |
| 144 | Notice of proposed sale | Jul 30, 2026 | — |
| 144 | Notice of proposed sale | Jul 29, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 29, 2026 | — |
| 144 | Notice of proposed sale | Jul 27, 2026 | — |
| 144 | Notice of proposed sale | Jul 21, 2026 | — |
| 144 | Notice of proposed sale | Jul 20, 2026 | — |
| 144 | Notice of proposed sale | Jul 17, 2026 | — |
| 144 | Notice of proposed sale | Jul 16, 2026 | — |
| 144 | Notice of proposed sale | Jul 15, 2026 | — |
| 144 | Notice of proposed sale | Jul 14, 2026 | — |
| 144 | Notice of proposed sale | Jul 13, 2026 | — |
| 144 | Notice of proposed sale | Jul 10, 2026 | — |
| 4 | Insider transaction | Jul 9, 2026 | Jul 7, 2026 |
| 144 | Notice of proposed sale | Jul 9, 2026 | — |
| 144 | Notice of proposed sale | Jul 8, 2026 | — |
| 144 | Notice of proposed sale | Jul 7, 2026 | — |
| 144 | Notice of proposed sale | Jul 7, 2026 | — |
| 144 | Notice of proposed sale | Jul 6, 2026 | — |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jul 1, 2026 |
| 144 | Notice of proposed sale | Jul 2, 2026 | — |
| 144 | Notice of proposed sale | Jul 1, 2026 | — |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 17, 2026 |
| 144 | Notice of proposed sale | Jun 18, 2026 | — |
| 144 | Notice of proposed sale | Jun 18, 2026 | — |
| 144 | Notice of proposed sale | Jun 18, 2026 | — |
| 4 | Insider transaction | Jun 17, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 5, 2026 |
| 144 | Notice of proposed sale | Jun 5, 2026 | — |
| 144 | Notice of proposed sale | Jun 5, 2026 | — |
| 4 | Insider transaction | Jun 4, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 4, 2026 | Jun 2, 2026 |
| 144 | Notice of proposed sale | Jun 3, 2026 | — |
| 144 | Notice of proposed sale | Jun 2, 2026 | — |
| 4 | Insider transaction | May 27, 2026 | May 22, 2026 |
| 144 | Notice of proposed sale | May 22, 2026 | — |
| 4 | Insider transaction | May 19, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 15, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 12, 2026 | — |
| 4 | Insider transaction | May 8, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 144 | Notice of proposed sale | May 7, 2026 | — |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2026 | May 6, 2026 |
| 144 | Notice of proposed sale | May 5, 2026 | — |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 30, 2026 | Apr 28, 2026 |
| 4 | Insider transaction | Apr 24, 2026 | Apr 22, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 24, 2026 | — |
| 144 | Notice of proposed sale | Apr 22, 2026 | — |
| 4 | Insider transaction | Apr 8, 2026 | Apr 6, 2026 |
| 4 | Insider transaction | Apr 8, 2026 | Apr 7, 2026 |
| 4 | Insider transaction | Apr 8, 2026 | Apr 7, 2026 |
| 144 | Notice of proposed sale | Apr 7, 2026 | — |
| 144 | Notice of proposed sale | Apr 7, 2026 | — |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 25, 2026 | Mar 25, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 23, 2026 |
| 144 | Notice of proposed sale | Mar 23, 2026 | — |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 144 | Notice of proposed sale | Mar 17, 2026 | — |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Mar 11, 2026 | Mar 9, 2026 |
| 144 | Notice of proposed sale | Mar 9, 2026 | — |
| 4 | Insider transaction | Mar 4, 2026 | Mar 3, 2026 |
| 144 | Notice of proposed sale | Mar 3, 2026 | — |
| S-8 | Employee stock plan registration | Feb 25, 2026 | — |
| 424B5 | Prospectus supplement | Feb 25, 2026 | — |
| 10-K | Annual report | Feb 25, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 25, 2026 | Feb 25, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 144 | Notice of proposed sale | Feb 19, 2026 | — |
| 144 | Notice of proposed sale | Feb 18, 2026 | — |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 6, 2026 | Feb 4, 2026 |
| 4 | Insider transaction | Feb 6, 2026 | Feb 3, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2026 | — |
| 144 | Notice of proposed sale | Feb 4, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 3, 2026 | — |
| 144 | Notice of proposed sale | Feb 3, 2026 | — |
| 4 | Insider transaction | Jan 22, 2026 | Jan 20, 2026 |
| 144 | Notice of proposed sale | Jan 20, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 3 | Initial insider ownership | Jan 9, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Jan 8, 2026 | Jan 6, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 144 | Notice of proposed sale | Jan 6, 2026 | — |
| 144 | Notice of proposed sale | Jan 5, 2026 | — |
| 4 | Insider transaction | Dec 30, 2025 | Dec 29, 2025 |
| 4 | Insider transaction | Dec 29, 2025 | Dec 22, 2025 |
| 144 | Notice of proposed sale | Dec 29, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 23, 2025 | — |
| 144 | Notice of proposed sale | Dec 22, 2025 | — |
| 4 | Insider transaction | Dec 19, 2025 | Dec 19, 2025 |
| 144 | Notice of proposed sale | Dec 19, 2025 | — |
| 4 | Insider transaction | Dec 17, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Other events
|
Dec 8, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Dec 5, 2025 | Dec 4, 2025 |
| 4 | Insider transaction | Dec 4, 2025 | Dec 2, 2025 |
| 144 | Notice of proposed sale | Dec 4, 2025 | — |
| 144 | Notice of proposed sale | Dec 2, 2025 | — |
| 4 | Insider transaction | Nov 26, 2025 | Nov 25, 2025 |
| 8-K |
Current report
Other events
|
Nov 26, 2025 | Nov 26, 2025 |
| 424B7 | Filing | Nov 26, 2025 | — |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 144 | Notice of proposed sale | Nov 19, 2025 | — |
| 4 | Insider transaction | Nov 6, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 6, 2025 | Nov 4, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Nov 5, 2025 | Nov 4, 2025 |
| 144 | Notice of proposed sale | Nov 4, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 29, 2025 | Oct 29, 2025 |
| 4 | Insider transaction | Oct 24, 2025 | Oct 23, 2025 |
| 144 | Notice of proposed sale | Oct 23, 2025 | — |
| 4 | Insider transaction | Oct 10, 2025 | Oct 10, 2025 |
| 144 | Notice of proposed sale | Oct 10, 2025 | — |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Sep 26, 2025 | Sep 25, 2025 |
| 144 | Notice of proposed sale | Sep 25, 2025 | — |
| 4 | Insider transaction | Sep 17, 2025 | Sep 15, 2025 |
| 4 | Insider transaction | Sep 12, 2025 | Sep 10, 2025 |
| 144 | Notice of proposed sale | Sep 10, 2025 | — |
| 8-K/A |
Amended current report
Unregistered share sale, Other events
|
Aug 29, 2025 | Jul 8, 2025 |
| 424B7 | Filing | Aug 29, 2025 | — |
| 4 | Insider transaction | Aug 28, 2025 | Aug 26, 2025 |
| 144 | Notice of proposed sale | Aug 26, 2025 | — |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 144 | Notice of proposed sale | Aug 18, 2025 | — |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 144 | Notice of proposed sale | Aug 11, 2025 | — |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure, Other events
|
Jul 8, 2025 | Jul 8, 2025 |
| 424B7 | Filing | Jul 8, 2025 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- RXRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Salt Lake City, UT
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1601830
- Former names
- Recursion Pharmaceuticals, LLC (until Dec 4, 2015)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.